ArriVent BioPharma (AVBP) EPS (Basic) (2023 - 2026)
ArriVent BioPharma (AVBP) reported EPS (Basic) of -$0.96 for Q1 2026, up 49.39% on a YoY basis from -$0.64 in Q1 2025, and down 4.01% sequentially from -$0.92 in Q4 2025.
ArriVent BioPharma (AVBP) EPS (Basic) (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of EPS (Basic) data on file, last reported at -$0.96 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 49.39% year-over-year to -$0.96; the trailing twelve-month figure through Mar 2026 stood at -$3.22 (up 14.29% YoY), and the FY2025 full-year result was -$4.32, down 69.06% from the prior year.
- EPS (Basic) retreated to -$0.96 in Q1 2026, from -$0.92 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.61 in Q3 2024 to a low of -$10.79 in Q2 2023.
- A 4-year average of -$3.37 and a median of -$0.92 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 93.95% in 2024 and slumped 173.14% in 2025, its largest moves.
- Tracing AVBP's EPS (Basic) over 4 years: stood at -$9.9 in 2023, then soared by 93.38% to -$0.66 in 2024, then tumbled by 40.95% to -$0.92 in 2025, then retreated by 4.01% to -$0.96 in 2026.
- Business Quant data shows AVBP's EPS (Basic) at -$0.96 in Q1 2026, -$0.92 in Q4 2025, and -$0.83 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | -0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.96 |
| Dec 31, 2025 | -0.92 |
| Sep 30, 2025 | -0.83 |
| Jun 30, 2025 | -0.90 |
| Mar 31, 2025 | -1.90 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -9.90 |
| Sep 30, 2023 | -5.52 |
| Jun 30, 2023 | -10.79 |
| Mar 31, 2023 | -9.45 |